PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28871303-6 2017 Polymeric dextrans coated with triazolylheptylmannoside (THM) ligands were highly potent, blocking the gB and DC-SIGN interaction at nanomolar concentrations. Dextrans 10-18 CD209 molecule Homo sapiens 110-117 25224349-9 2014 We consider dextran a promising molecule for the development of lectin-glycan interaction-blocking molecules (such as DC-SIGN inhibitors) that could be applied in the treatment of diseases including tuberculosis, influenza, hepatitis B and C, human immunodeficiency virus infection and AIDS, etc. Dextrans 12-19 CD209 molecule Homo sapiens 118-125 25224349-10 2014 Dextran derivatives indeed change the pathology of infections dependent on DC-SIGN and mannose receptors. Dextrans 0-7 CD209 molecule Homo sapiens 75-82